Back to top

moving-average-crossover: Archive

Zacks Equity Research

StepStone Group (STEP) Surges 6.9%: Is This an Indication of Further Gains?

StepStone Group (STEP) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

STEPNo Net Change OPRTPositive Net Change

Zacks Equity Research

Civeo (CVEO) Surges 6.7%: Is This an Indication of Further Gains?

Civeo (CVEO) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

CVEOPositive Net Change HPositive Net Change

Zacks Equity Research

ResMed (RMD) Soars 4.2%: Is Further Upside Left in the Stock?

ResMed (RMD) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.

RMDPositive Net Change EOLSNegative Net Change

Zacks Equity Research

Silicon Motion (SIMO) Just Flashed Golden Cross Signal: Do You Buy?

Good things could be on the horizon when a stock surpasses the 20-day simple moving average. How should investors react?

SIMONegative Net Change

Zacks Equity Research

GFL Environmental (GFL) Surges 8.0%: Is This an Indication of Further Gains?

GFL Environmental (GFL) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

GFLPositive Net Change ONTPositive Net Change

Zacks Equity Research

Profound Medical (PROF) Moves 8.2% Higher: Will This Strength Last?

Profound Medical (PROF) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

PROFNegative Net Change STVNNegative Net Change

Zacks Equity Research

Bioventus (BVS) Soars 12.4%: Is Further Upside Left in the Stock?

Bioventus (BVS) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

BVSNo Net Change RIGLNegative Net Change

Zacks Equity Research

Ono Pharmaceutical Co. (OPHLF) Moves 10.4% Higher: Will This Strength Last?

Ono Pharmaceutical Co. (OPHLF) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

OPHLFPositive Net Change BCRXNo Net Change

Zacks Equity Research

Strength Seen in Fidus Investment (FDUS): Can Its 5.6% Jump Turn into More Strength?

Fidus Investment (FDUS) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

FDUSPositive Net Change TSLXPositive Net Change

Zacks Equity Research

Strength Seen in Alvopetro Energy (ALVOF): Can Its 7.4% Jump Turn into More Strength?

Alvopetro Energy (ALVOF) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

ALVOFPositive Net Change XIFRPositive Net Change